136 related articles for article (PubMed ID: 1362630)
1. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity.
Concha M; Graham NM; Muñoz A; Vlahov D; Royal W; Updike M; Nance-Sproson T; Selnes OA; McArthur JC
Am J Epidemiol; 1992 Dec; 136(11):1338-48. PubMed ID: 1362630
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological performance in HIV/AIDS intravenous drug users.
Vazquez-Justo E; Rodríguez Alvarez M; Carro Ramos J
J Clin Exp Neuropsychol; 2003 Sep; 25(6):852-65. PubMed ID: 13680462
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users.
Margolin A; Avants SK; Warburton LA; Hawkins KA
AIDS Patient Care STDS; 2002 Jun; 16(6):255-67. PubMed ID: 12133261
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.
Tran SD; Williams AB; Truong HT; Do NH
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):283-7. PubMed ID: 9495230
[TBL] [Abstract][Full Text] [Related]
6. Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users.
Boccellari AA; Chambers DB; Dilley JW; Shore MD; Tauber MA; Moss AR; Osmond DH
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1040-9. PubMed ID: 7916050
[TBL] [Abstract][Full Text] [Related]
7. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland.
Vlahov D; Muñoz A; Anthony JC; Cohn S; Celentano DD; Nelson KE
Am J Epidemiol; 1990 Nov; 132(5):847-56. PubMed ID: 2239899
[TBL] [Abstract][Full Text] [Related]
8. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
[TBL] [Abstract][Full Text] [Related]
9. Effects of HIV seropositivity and drug abuse on cognitive function.
Grassi MP; Perin C; Clerici F; Zocchetti C; Borella M; Cargnel A; Mangoni A
Eur Neurol; 1997; 37(1):48-52. PubMed ID: 9018033
[TBL] [Abstract][Full Text] [Related]
10. HIV infection and cognition in intravenous drug users: long-term follow-up.
Selnes OA; Galai N; McArthur JC; Cohn S; Royal W; Esposito D; Vlahov D
Neurology; 1997 Jan; 48(1):223-30. PubMed ID: 9008522
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory correlates of human immunodeficiency virus infection in a cohort of intravenous drug users from New York, NY.
el-Sadr W; Goetz RR; Sorrell S; Joseph M; Ehrhardt A; Gorman JM
Arch Intern Med; 1992 Aug; 152(8):1653-9. PubMed ID: 1353953
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological impairment among intravenous drug users in pre-AIDS stages of HIV infection.
Wellman MC
Int J Neurosci; 1992; 64(1-4):183-94. PubMed ID: 1342038
[TBL] [Abstract][Full Text] [Related]
13. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users.
Alcabes P; Muñoz A; Vlahov D; Friedland G
Ann Epidemiol; 1994 Jan; 4(1):17-26. PubMed ID: 7911376
[TBL] [Abstract][Full Text] [Related]
14. Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV).
Nelson KE; Vlahov D; Cohn S; Odunmbaku M; Lindsay A; Antohony JC; Hook EW
J Infect Dis; 1991 Sep; 164(3):457-63. PubMed ID: 1869836
[TBL] [Abstract][Full Text] [Related]
15. HIV antibodies among intravenous drug users in Bahrain.
al-Haddad MK; Khashaba AS; Baig BZ; Khalfan S
J Commun Dis; 1994 Sep; 26(3):127-32. PubMed ID: 7868834
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects.
Selnes OA; McArthur JC; Royal W; Updike ML; Nance-Sproson T; Concha M; Gordon B; Solomon L; Vlahov D
Neurology; 1992 Oct; 42(10):1924-30. PubMed ID: 1407574
[TBL] [Abstract][Full Text] [Related]
17. Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users.
Concha M; Selnes OA; McArthur JC; Nance-Sproson T; Updike ML; Royal W; Solomon L; Vlahov D
Int J Addict; 1995 May; 30(7):823-41. PubMed ID: 7558472
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of alcohol consumption and HIV acquisition among injection drug users.
Howe CJ; Cole SR; Ostrow DG; Mehta SH; Kirk GD
AIDS; 2011 Jan; 25(2):221-8. PubMed ID: 21099668
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological performance in HIV-1-infected drug abusers.
Grassi MP; Perin C; Clerici F; Zocchetti C; Cargnel A; Mangoni A
Acta Neurol Scand; 1993 Aug; 88(2):119-22. PubMed ID: 8213055
[TBL] [Abstract][Full Text] [Related]
20. Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men.
Concha M; Selnes OA; Vlahov D; Nance-Sproson T; Updike M; Royal W; Palenicek J; McArthur JC
Neuroepidemiology; 1997; 16(2):78-85. PubMed ID: 9057169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
